While prior breast cancer studies have noted a high rate of EGFR mutations in study samples with predominantly Asian participants22 compared to predominantly European participants23, there have been no studies that systematically compared frequencies in the same dataset that have been large enough to demonstrate this difference with a high degree of significance. The gene discussed is EGFR; the disease is breast carcinoma.